APGE Live signaler | Maksimer profitt med Getagraph.com

KJøP 120143 min ago

@ $35.28

Utstedt: 14 feb 2024 @ 21:02

Avkastning: 48.02%

Forrige signal: feb 13 - 18:37

Forrige signal: Selg

Avkastning: 0.28 %

Live Chart Being Loaded With Signals

Commentary (7 mai 2024 @ 22:00):

Stats
Dagens volum	183 246
Gjennomsnittsvolum	705 865
Markedsverdi	2.95B
EPS	$0 ( 2024-03-11 )
Neste inntjeningsdato	( $-0.600 ) 2024-06-04
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.0910 (0.17%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-29	Fairmount Funds Management Llc	Buy	51 166	Common Stock
2024-01-29	Fairmount Funds Management Llc	Sell	892 529	Common Stock
2023-12-18	Henderson Michael Thomas	Buy	398 512	Stock Option (Right to Buy)
2023-07-13	Fairmount Funds Management Llc	Buy	1 992 734	Common Stock
2023-07-13	Fairmount Funds Management Llc	Buy	892 529	Common Stock

INSIDER POWER
47.28
Last 9 transactions
Buy: 3 438 612 \| Sell: 892 529

Volum Korrelasjon

Lang: -0.20 (neutral)

Kort: -0.90 (strong negative)

Signal:(56.179) Neutral

Apogee Therapeutics, Inc. Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Apogee Therapeutics, Inc. Korrelasjon - Valuta/Råvare

-0.25
( neutral )

-0.04
( neutral )

0.00
( neutral )

0.21
( neutral )

-0.61
( weak negative )

0.43
( neutral )

Apogee Therapeutics, Inc. Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-1.660

FY	2023
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-1.660

FY	2022
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-0.790

Financial Reports:

No articles found.

Apogee Therapeutics, Inc.

Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs include APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. The company was founded in 2022 and is based in Waltham, Massachusetts.